-
EP4042436
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4042436
| EP4042436 - BLOOD GLUCOSE CONTROL SYSTEM [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 02.08.2024 Database last updated on 19.10.2024 | |
| Former | Request for examination was made Status updated on 15.07.2022 | ||
| Former | The international publication has been made Status updated on 10.04.2021 | Most recent event Tooltip | 02.08.2024 | Application deemed to be withdrawn | published on 04.09.2024 [2024/36] | Applicant(s) | For all designated states Beta Bionics, Inc. 11 Hughes Irvine, California 92618 / US | [2022/33] | Inventor(s) | 01 /
EL-KHATIB, Firas, H. 59 Brainerd Road, Apt 218 Alston, Massachusetts 02134 / US | 02 /
DAMIANO, Edward, R. 22 Putnam Road Acton, Massachusetts 01720 / US | 03 /
RASKIN, Edward, B. 104 Tandem Irvine, California 92618 / US | 04 /
LIM, David, Chi-Wai 206 Parkwood Irvine, California 92620 / US | 05 /
ROSINKO, Michael, J. 211 South Yorkshire Circle Anaheim, California 92808 / US | [2022/33] | Representative(s) | Hertin und Partner Rechts- und Patentanwälte PartG mbB Kurfürstendamm 54/55 10707 Berlin / DE | [2022/33] | Application number, filing date | 20872651.3 | 02.10.2020 | [2022/33] | WO2020US54130 | Priority number, date | US201962910970P | 04.10.2019 Original published format: US 201962910970 P | US201962911017P | 04.10.2019 Original published format: US 201962911017 P | US201962911143P | 04.10.2019 Original published format: US 201962911143 P | US202062987842P | 10.03.2020 Original published format: US 202062987842 P | US202063037472P | 10.06.2020 Original published format: US 202063037472 P | WO2020US42195 | 15.07.2020 Original published format: PCT/US2020/042195 | WO2020US42198 | 15.07.2020 Original published format: PCT/US2020/042198 | WO2020US42269 | 16.07.2020 Original published format: PCT/US2020/042269 | [2022/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021067856 | Date: | 08.04.2021 | Language: | EN | [2021/14] | Type: | A1 Application with search report | No.: | EP4042436 | Date: | 17.08.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 08.04.2021 takes the place of the publication of the European patent application. | [2022/33] | Search report(s) | International search report - published on: | AU | 08.04.2021 | (Supplementary) European search report - dispatched on: | EP | 06.09.2023 | Classification | IPC: | G16H20/17, A61M5/172, A61M5/142, G16H40/60 | [2022/33] | CPC: |
G16H40/40 (EP,AU,IL);
A61B5/14532 (EP,IL);
A61B5/4839 (EP,IL);
A61M5/14244 (EP,AU,IL);
A61M5/172 (EP,IL);
A61M5/1723 (EP,AU,IL);
G06F8/65 (EP,IL);
G06F8/656 (AU);
G16H15/00 (EP,AU,IL);
G16H20/17 (EP,IL);
G16H40/60 (AU);
G16H40/63 (EP,IL);
G16H40/67 (EP,AU,IL);
G16H50/20 (EP,IL);
A61M2005/1401 (AU);
A61M2005/14208 (EP,AU,IL);
A61M2205/18 (EP,AU,IL);
A61M2205/3303 (EP,IL);
A61M2205/3553 (EP,AU,IL);
A61M2205/3569 (EP,AU,IL);
A61M2205/3584 (EP,AU,IL);
A61M2205/3592 (EP,AU,IL);
A61M2205/502 (EP,IL);
A61M2205/505 (AU);
| C-Set: |
A61M2230/201, A61M2230/005 (AU)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/33] | Title | German: | SYSTEM FÜR BLUTZUCKERKONTROLLE | [2022/33] | English: | BLOOD GLUCOSE CONTROL SYSTEM | [2022/33] | French: | SYSTÈME DE RÉGULATION DE LA GLYCÉMIE | [2022/33] | Entry into regional phase | 02.05.2022 | National basic fee paid | 02.05.2022 | Search fee paid | 02.05.2022 | Designation fee(s) paid | 02.05.2022 | Examination fee paid | Examination procedure | 08.05.2021 | Request for preliminary examination filed International Preliminary Examining Authority: AU | 02.05.2022 | Examination requested [2022/33] | 10.11.2022 | Amendment by applicant (claims and/or description) | 09.04.2024 | Application deemed to be withdrawn, date of legal effect [2024/36] | 30.04.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2024/36] | Fees paid | Renewal fee | 26.10.2022 | Renewal fee patent year 03 | 10.10.2023 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]US2017053101 (BOOTH ROBERT C [US], et al); | [XI]US2018185587 (BRAUKER JAMES H [US], et al); | [XI]US2019214124 (MOUGIAKAKOU STAVROULA [CH], et al); | [E]WO2021011738 (BETA BIONICS INC [US], et al) | International search | [X]US2009006061 (THUKRAL AJAY [US], et al); | [X]US2011021898 (WEI CHARLES [US], et al); | [X]US2012065894 (TUBB ANDREW [FR], et al); | [X]US2015217053 (BOOTH ROBERT C [US], et al); | [X]US2016224756 (BERGER LARS [DE], et al); | [X]US2018185587 (BRAUKER JAMES H [US], et al); | [X]US2019214124 (MOUGIAKAKOU STAVROULA [CH], et al); | [X]US2019247578 (DESBOROUGH LANE [US], et al) |